Literature DB >> 34524644

Pharmacotherapy for the Treatment of Gastric Antral Vascular Ectasia: A Narrative Review.

Mengyuan Peng1,2, Xiaozhong Guo1, Fangfang Yi1, Fernando Gomes Romeiro3, Andrea Mancuso4, Xingshun Qi5.   

Abstract

Gastric antral vascular ectasia (GAVE) is an uncommon clinical entity leading to recurrent gastrointestinal bleeding. There is no consensus regarding treatment of GAVE. Endoscopic therapy is the preferred treatment option, but has a fairly high recurrence rate. Surgical resection can completely resolve GAVE, but is invasive with a relatively high risk of postoperative complications. Recently, the role of pharmacotherapy for GAVE has been recognized. However, the evidence is limited to scattered case reports or small case series. This review comprehensively summarizes the efficacy and side effects of drugs commonly used for the treatment of GAVE, including octreotide, cyproheptadine, cyclophosphamide, prednisolone, estrogen-progesterone, thalidomide, bevacizumab, and tranexamic acid.
© 2021. The Author(s), under exclusive licence to Springer Healthcare Ltd., part of Springer Nature.

Entities:  

Keywords:  Gastric antral vascular ectasia; Gastrointestinal bleeding; Pathogenesis; Pharmacotherapy; Refractory anemia

Mesh:

Year:  2021        PMID: 34524644     DOI: 10.1007/s12325-021-01912-6

Source DB:  PubMed          Journal:  Adv Ther        ISSN: 0741-238X            Impact factor:   3.845


  60 in total

1.  Gastritis with veno-capillary ectasia as a source of massive gastric hemorrhage.

Authors:  J A RIDER; A P KLOTZ; J B KIRSNER
Journal:  Gastroenterology       Date:  1953-05       Impact factor: 22.682

2.  Neuroendocrine cell proliferations in gastric antral vascular ectasia.

Authors:  J R Lowes; J Rode
Journal:  Gastroenterology       Date:  1989-07       Impact factor: 22.682

3.  Successful treatment of refractory gastric antral vascular ectasia by distal gastrectomy: a case report.

Authors:  Ting Jin; Bao-Ying Fei; Wei-Hua Zheng; Yong-Xiang Wang
Journal:  World J Gastroenterol       Date:  2014-10-14       Impact factor: 5.742

4.  A case of gastric antral vascular ectasia--increase of neuroendocrine cells in the antrum.

Authors:  Y Yamaoka; H Konishi; T Kodama; K Kashima; T Yamaguchi; M Imamura; T Ogasawara; M Kizu
Journal:  J Gastroenterol       Date:  1995-06       Impact factor: 7.527

5.  Gastric mucosal vascular ectasias causing bleeding in cirrhosis. A distinct entity associated with hypergastrinemia and low serum levels of pepsinogen I.

Authors:  E Quintero; J M Pique; J A Bombi; J M Bordas; J Sentis; M Elena; J Bosch; J Rodes
Journal:  Gastroenterology       Date:  1987-11       Impact factor: 22.682

6.  An Analysis of the Clinical, Laboratory, and Histological Features of Striped, Punctate, and Nodular Gastric Antral Vascular Ectasia.

Authors:  Arul Thomas; David Koch; William Marsteller; David Lewin; Adrian Reuben
Journal:  Dig Dis Sci       Date:  2018-02-15       Impact factor: 3.199

7.  Increased gastric PGE2 biosynthesis in cirrhotic patients with gastric vascular ectasia.

Authors:  E Saperas; R M Perez Ayuso; E Poca; J M Bordas; J Gaya; J M Pique
Journal:  Am J Gastroenterol       Date:  1990-02       Impact factor: 10.864

8.  The watermelon stomach: long-term outcome in patients treated with Nd:YAG laser therapy.

Authors:  S M Liberski; T J McGarrity; R J Hartle; V Varano; D Reynolds
Journal:  Gastrointest Endosc       Date:  1994 Sep-Oct       Impact factor: 9.427

9.  Endoscopic resolution and recurrence of gastric antral vascular ectasia after serial treatment with argon plasma coagulation.

Authors:  Shashank Garg; Bilal Aslam; Nicholas Nickl
Journal:  World J Gastrointest Endosc       Date:  2017-06-16

10.  Long-term follow-up in patients with gastric antral vascular ectasia (GAVE) after treatment with endoscopic band ligation (EBL).

Authors:  John Eccles; Vanessa Falk; Aldo J Montano-Loza; Sergio Zepeda-Gómez
Journal:  Endosc Int Open       Date:  2019-11-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.